Nectar Life Sciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA1131700
EBIT271130
Earning Per Share-31-1
Expenses1,4341,5101,471
Net Profit-7325-24
Net Profit Margin-41-1
Operating Profit Margin696
Profit Before Tax-8534-42
Dividends Per Share000
Operation Revenue1,5471,6801,567

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
202300377.40NA868.45
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Nectar Life Sciences is 0 as of 6/9/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020202020
Operating Activities65239285285285
Investing Activities-29-26-33-33-33
Financing Activities-40-201-252-252-252
Others00000
Net Cash Flow-412-0-0-0

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20201,392.41-783.52-444.66164.23
20201,468.841,106.99-890.581,685.25
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Nectar Life Sciences is 285 as of 6/9/2023